Get your Emails warmed up and ready to send

Build sender reputation and reach more inboxes with automated email warmup.

Warm up your emails

Starting at $49/month

Start Warming Up

Martin J. G.

Co-founder and Chief Commercial Officer @Sunstone Health

Boston, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Aug 2018 — Present

Co-founder and Chief Commercial Officer @Sunstone Health

Boston, MA, US

Co-founder of this personalized medicine healthcare platform company serving the needs of health care institutions, hospitals, medical clinics, health insurers and (most importantly) patients-in-need and related stakeholders in the commercial development of personalized medicine operations integrated into existing provider facilities.

EDUCATION

1974 — 1978

Harvard University

Bachelor of Arts (B.A.), Government

ABOUT MARTIN J. G.

Venture investor/asset manager for 35 years. Numerous board positions held over many years in developing/growing companies across a wide range of industries. Presently focused on investments in rapidly growing technology companies in the Personalized Medicine and Health Care industries, assisting entrepreneurs and physicians/scientists in advancing the development of therapeutics and diagnostic tools. Working on an urgent and important mission to get improved care to patients suffering from rare diseases (especially in the neurodegenerative cohorts) as the Chief Commercial Officer of TMA Precision Health (TMA), a Boston based business, a company that is a spinout of the Brigham and Women\'s Hospital Translational Medicine Accelerator on whose Board I had the privilege of serving. We are building clinical/genomic patient data sets that inform proprietary Artificial Intelligence models and software that facilitates more precise care paths for patients, better diagnostic tools for physicians, lower costs of care for payers/insurers and more precise and focused data sets for the pharmaceutical industry that yield targeted therapies for patients suffering from the most pernicious neurodegenerative diseases such as pediatric uncontrolled seizure syndrome. We have run a successful pilot program in under resourced patient populations in Latin America, and are bringing our success to the United States to partner with all of the key stakeholders (e.g. patients, providers, payers and pharma) in our urgent mission to help the most underserved cohorts suffering from rare diseases. I am blessed to be sharing this important mission with a team of brilliant scientists, physicians and software engineers, including the Chief Innovation Officer and the Head of Neuroradiology at MGB (Mass General Brigham), along with the world\'s most distinguished researchers and patient advocates in the rare disease space.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.